Delivery Order SPE2DB22D2206-SPE2DB25FHL82

Award Date 6/16/25
Potential Completion Date 6/17/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,897.80 firm fixed-price delivery order covers the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a medical product, with a completion date of December 26, 2023. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,876.00, is a firm fixed-price Delivery Order for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product. The contract has an ultimate completion date of August 1, 2024. Amerisourcebergen, through its Corporate Office division, is the prime contractor on this award and is not operating under a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,772.55, is a Firm Fixed Price Delivery Order with a completion date of February 3, 2025. The award covers the procurement of pharmaceutical products, including AMLOD-VALSA-HCTZ 10-320-25 MG 30S. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,626.87 firm fixed-price delivery order is for the medication AMLOD-VALSA-HCTZ 10-160-12.5MG 30S, and has a completion date of November 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,776.04, is for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a medical product, and has an ultimate completion date of November 20, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,027.89 fixed-price delivery order is for the supply of AMLOD-VALSA-HCTZ 5-160-12.5 MG 30S, a prescription medication. The contract has a completion date of June 10, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,446.30 firm fixed-price delivery order is for AMLOD-VALSA-HCTZ 10-160-25 MG 30S, a cardiovascular medication. The contract has an ultimate completion date of March 12, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $4,546.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product AMLOD-VALSA-HCTZ 10-320-25 MG 30S, which is used to treat cardiovascular conditions. The contract is a delivery order and has a firm fixed price pricing type, with a period of performance running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,321.05, is a firm fixed-price delivery order that has an ultimate completion date of November 7, 2024. The award is for the provision of AMLOD-VALSA-HCTZ 10-320-25 MG 30S pharmaceutical products. This contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $13,356.08 firm-fixed-price delivery order is for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product. The contract has an ultimate completion date of September 19, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FHL82
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,801.76 firm fixed-price delivery order is for the supply of 30-count packages of the pharmaceutical product AMLOD-VALSA-HCTZ 10-320-25 MG. The contract has an ultimate completion date of June 17, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This prime contract enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/15/25, 9:49 AM